SARAH WICK: Open Payments
NPI 1215491873 · NORTH EAST, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,686 in 161 payments from 26 companies in 2025. Trend: 2023 $3,019 · 2024 $2,784 · 2025 $3,686
Food & beverage: $3,686
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $539 |
| PFIZER INC. | 26 | $514 |
| ABBVIE INC. | 30 | $491 |
| Madrigal Pharmaceuticals | 3 | $326 |
| Exact Sciences Corporation | 9 | $266 |
| Amgen Inc. | 10 | $242 |
| Lilly USA, LLC | 13 | $203 |
| Boston Scientific Corporation | 6 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $153 |
| AstraZeneca Pharmaceuticals LP | 7 | $119 |
Products named: NURTEC ODT, REZDIFFRA, Ozempic, Cologuard Collection Kit, OTEZLA, WATCHMAN FLX, QULIPTA, Wegovy.
Industry payments across PA — which companies pay providers there.
